Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Echocardiography × Dermatologic × Clear all

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Breast 4 Lymphoid 3 Thoracic 2 Other 2 Sarcoma 1 Plasma cell 1 Other hematologic neoplasm 1 Myeloid 1 Gynecologic 1 Genitourinary 1 Dermatologic 1

Conditions

Melanoma 1 Cardiotoxicity 1

Interventions

Surveys and Questionnaires 18 Blood Specimen Collection 18 Nivolumab 12 Ipilimumab 11 pembrolizumab 10 Biopsy 9 Gene Expression Profiling 8 trametinib 7 dabrafenib 6 Therapeutics 6 Specimen Handling 6 Flow Cytometry 6 Watchful Waiting 5 Tomography, Optical Coherence 5 Polymerase Chain Reaction 5 Imiquimod 5 Amplified Fragment Length Polymorphism Analysis 5 Immunotherapy 4 Immunohistochemistry 4 Dermoscopy 4 Data Collection 4 3-ingenyl angelate 4 cemiplimab 3 atezolizumab 3 Surgical Procedures, Operative 3 Restraint, Physical 3 Psychiatric Rehabilitation 3 Mohs Surgery 3 Microscopy, Confocal 3 Introns 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06605833 2025-10-01

CARD-IO

Royal Marsden NHS Foundation Trust

Enrolling by invitation

Melanoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡